Do amount of variant differentiation and mitotic rate in bladder cancer change with neoadjuvant chemotherapy?


Neoadjuvant chemotherapy (NAC) is currently recommended to all candidate patients with muscularis propria-invasive bladder cancer. However, NAC is effective in only a subset of patients, and predictors of response are lacking. Our study aimed to characterize tumoral changes with NAC usage and to identify features at bladder biopsy/transurethral resection… (More)
DOI: 10.1016/j.humpath.2015.05.020

6 Figures and Tables


  • Presentations referencing similar topics